Skip to main content

Table 1 Echocardiographic data of SHR

From: Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study

 

Chamber and wall dimensions

Systolic function

Month(s)

LVEDD(mm)

LVESD(mm)

IVS(mm)

LVPW(mm)

EF(%)

FS(%)

1

3.79±0.29

1.71±0.09

1.28±0.18

1.14±0.08

90.87±0.95

62.32±1.05

3

4.79±0.22**

1.89±0.09

1.60±0.09**

1.60±0.14**

91.45±0.54

63.46±1.69

6

5.22±0.42**

1.95±0.07

1.79±0.11**

2.39±0.23**

90.67±0.65

62.73±1.29

9

5.51±0.38**

2.60±0.24**

1.83±0.12**

2.51±0.20**

91.15±0.69

62.89±1.94

12

5.61±0.25**

2.63±0.14**

2.05±0.20**

2.87±0.17**

91.68±0.76

63.40±1.64

15

6.17±0.40**††

3.61±0.16**††

2.08±0.10**

3.05±0.11**†

91.11±0.77

63.17±1.51

18

5.97±0.38**†

3.72±0.20**††

1.93±0.10**†

3.55±0.24**††

88.03±1.46**††

57.33±2.65**††

 

Diastolic function

Month(s)

E/A

E′ /A′

E/E′

DT(ms)

IVRT(ms)

1

2.85±0.20

1.76±0.09

19.23±3.05

22.67±2.59

30.66±11.95

3

2.78±0.26

1.72±0.09

27.12±2.06**

21.39±1.27

37.50±2.20

6

2.26±0.43*

0.56±0.05**

29.66±3.64**

26.67±4.77*

39.14±6.54*

9

2.15±0.34**

0.63±0.07**

31.65±3.00**

24.41±2.55*

37.22±13.07

12

2.19±0.32**

0.55±0.09**

35.36±4.29**

24.17±4.02*

38.75±4.54*

15

2.06±0.09**†

0.57±0.04**

36.93±1.31**

22.09±6.48

46.67±2.35**

18

1.98±0.23**††

0.59±0.03**

39.82±4.41**††

26.33±3.31*

40.17±7.60**

  1. All data are means ± SD. * p<0.05 vs. 1 month; ** p<0.01 vs. 1 month; † p<0.05 vs. 12 month; †† p<0.01 vs. 12 month.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X